• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Endonovo Therapeutics

Endonovo Therapeutics settles with PE shop Kodiak Capital

September 22, 2017 By Fink Densford

Endonovo Therapeutics (OTC:ENDV) said today it has settled a lawsuit between it and Kodiak Capital Group over a contemplated equity investment by the firm in Endovo. Los Angeles-based Endonovo said that the groups had reached a settlement agreement and dismissed all complaints and cross-complaints from the contemplated investments. As part of the settlement, Kodiak is returning […]

Filed Under: Legal News Tagged With: Endonovo Therapeutics

Anonymous strategic investor puts another $5m into Endonovo’s Immunotronics

November 30, 2016 By Brad Perriello

Endonovo Therapeutics (OTC:ENDV) said this week that it inked a $5 million deal with an anonymous strategic investor aimed at retiring its convertible debt, launching pre-clinical studies of its Immunotronics platform and uplisting its shares. The Los Angeles-based company, which is developing technology it calls “Immunotronics” to stimulate liver regeneration and treat inflammatory conditions, said it […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Endonovo Therapeutics

Endonovo Therapeutics raises $10 million

October 14, 2016 By Fink Densford

Endonovo Therapeutics (OTC:ENDV) said today that it landed a $10 million funding agreement with an institutional investor. The funding consists of $1 million in convertible notes, with $600,000 already received and $400,000 to be received upon SEC registration approval, and up to $9 million through a securities purchase agreement after 30 days from its SEC registration date. […]

Filed Under: Clinical Trials, Funding Roundup Tagged With: Endonovo Therapeutics

Rio Grande Neurosciences backs out of $22m Endonovo deal

August 22, 2016 By Brad Perriello

Rio Grande Neurosciences last week backed out of its pending acquisition by Endonovo Therapeutics (OTC:ENDV), after seeking to renegotiate the terms of the $22 million deal, Endonovo said. Steven Gluckstern, chairman & CEO of Santa Fe-based Rio Grande, dissolved a binding letter of intent August 19 “following its request to renegotiate the terms of the binding LOI, […]

Filed Under: Mergers & Acquisitions, Neurological Tagged With: Endonovo Therapeutics, Rio Grande Neurosciences

Endonovo Therapeutics raises $10m for Rio Grande buy

July 15, 2016 By Brad Perriello

Endonovo Therapeutics (OTC:ENDV) said today that it raised $10 million it plans to use to fund the $22 million acquisition of Rio Grande Neurosciences. The backing from an unnamed institutional investor consists of $1 million in convertible notes and another $9 million in a securities purchase agreement, Los Angeles-based Endonovo said. The company said it’s received $400,000 […]

Filed Under: Funding Roundup, Mergers & Acquisitions, Neurological, Wall Street Beat Tagged With: Endonovo Therapeutics, Rio Grande Neurosciences

Endonovo Therapeutics inks $22m deal for Rio Grande Neurosciences

July 11, 2016 By Brad Perriello

Endonovo Therapeutics (OTC:ENDV) said today that it agreed to pay $21.5 million to acquire Rio Grande Neurosciences and its non-invasive devices for treating brain disorders. The cash-and-stock deal calls for Endonovo to put up $1.5 million in cash, another $15 million in ENDV shares and $5 million worth of warrants. The companies signed a binding letter […]

Filed Under: Mergers & Acquisitions, Neurological, Wall Street Beat Tagged With: Endonovo Therapeutics, Rio Grande Neurosciences

Endonovo Therapeutics lands $10M

February 14, 2014 By Chris Walker Leave a Comment

Endonovo Therapeutics lands $10M

Endonovo Therapeutics said it raised $10 million in a private placement with an unnamed investor.

The Woodland Hills, Calif.-based company is developing non-invasive, electromagnetic therapies with time-varying electromagnetic fields to regenerate tissue and organs that have been damaged by age or disease.

Filed Under: Funding Roundup, News Well Tagged With: Endonovo Therapeutics

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy